Cargando…
LAG-3-Expressing Tumor-Infiltrating T Cells Are Associated with Reduced Disease-Free Survival in Pancreatic Cancer
SIMPLE SUMMARY: In light of the majority of pancreatic cancer patients not responding to current immune checkpoint blockade, alternative immunotherapeutic targets need to be identified. In this study, we employed multiplex immunofluorescence to investigate the expression of co-stimulatory and inhibi...
Autores principales: | Seifert, Lena, Plesca, Ioana, Müller, Luise, Sommer, Ulrich, Heiduk, Max, von Renesse, Janusz, Digomann, David, Glück, Jessica, Klimova, Anna, Weitz, Jürgen, Schmitz, Marc, Seifert, Adrian M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998134/ https://www.ncbi.nlm.nih.gov/pubmed/33803936 http://dx.doi.org/10.3390/cancers13061297 |
Ejemplares similares
-
Neoadjuvant chemotherapy drives intratumoral T cells toward a proinflammatory profile in pancreatic cancer
por: Heiduk, Max, et al.
Publicado: (2022) -
VISTA Ligation Reduces Antitumor T-Cell Activity in Pancreatic Cancer
por: Digomann, David, et al.
Publicado: (2023) -
Clinical Significance of Tumor-Infiltrating Conventional and Plasmacytoid Dendritic Cells in Pancreatic Ductal Adenocarcinoma
por: Plesca, Ioana, et al.
Publicado: (2022) -
TIGIT Expression Delineates T-cell Populations with Distinct Functional and Prognostic Impact in Pancreatic Cancer
por: Heiduk, Max, et al.
Publicado: (2023) -
Serum immune checkpoint profiling identifies soluble CD40 as a biomarker for pancreatic cancer
por: Digomann, David, et al.
Publicado: (2023)